Implementation of long-acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations.

MLA

Gutner, Cassidy A., et al. “Implementation of Long-Acting Cabotegravir and Rilpivirine: Primary Results from the Perspective of Staff Study Participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations.” Journal of the International AIDS Society, vol. 27, no. 7, July 2024, p. e26243. EBSCOhost, https://doi.org/10.1002/jia2.26243.

APA

Gutner, C. A., Hocqueloux, L., Jonsson-Oldenbüttel, C., Vandekerckhove, L., van Welzen, B. J., Slama, L., Crusells-Canales, M., Sierra, J. O., DeMoor, R., Scherzer, J., Ait-Khaled, M., Bontempo, G., Gill, M., Patel, N., D’Amico, R., Hove, K., Baugh, B., Barnes, N., Hadi, M., … Czarnogorski, M. (2024). Implementation of long-acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations. Journal of the International AIDS Society, 27(7), e26243. https://doi.org/10.1002/jia2.26243

Chicago

Gutner, Cassidy A, Laurent Hocqueloux, Celia Jonsson-Oldenbüttel, Linos Vandekerckhove, Berend J van Welzen, Laurence Slama, María Crusells-Canales, et al. 2024. “Implementation of Long-Acting Cabotegravir and Rilpivirine: Primary Results from the Perspective of Staff Study Participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations.” Journal of the International AIDS Society 27 (7): e26243. doi:10.1002/jia2.26243.